Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesIcecure Medical

Icecure Medical

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.82 USD 0.14 ( 20.46%)
Last update at 2026-11-09T15:46:00Z
VOLUME
498635
Market Cap
49.86M

Momentum Score

…

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.75
Low
0.95
High
52 Week Price Range
0.52
Low
1.57
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

IceCure Medical develops and commercializes minimally invasive cryoablation systems for treating benign and malignant tumors, with commercial operations in select markets and ongoing efforts to expand indications and regulatory approvals. Long-term growth drivers include broader adoption of image-guided, tissue-sparing oncology procedures, accumulation of clinical evidence and expansion into new geographies, which may benefit revenue growth and market adoption. Investors may find exposure to a niche interventional oncology device company attractive for potential substitution of surgery in specific indications.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.68
Dividend Yield
-
Revenue TTM
3.23M
Revenue Per Share
0.07
Gross Profit TTM
1.45M
Debt / Equity
0.05
ROE
-77.97%
Net Debt
-9.93M
ROCE
-133.50%
Diluted EPS TTM
-0.32

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -16.98M -9.89M -4.69M -4.77M -3.53M
Net income -17.22M -10.07M -4.78M -4.76M -3.53M
Selling general administrative 5.86M 4.12M 1.76M 1.32M 1.07M
Selling and marketing expenses 3.20M 1.92M 1.11M 1.02M 0.61M
Gross profit 1.45M 2.19M 2.66M 0.58M 0.45M
Reconciled depreciation 0.25M 0.13M 0.86M 0.54M 0.12M
Ebit -16.74M -9.72M -4.36M -4.61M -3.45M
Ebitda -16.49M -9.60M -4.34M -4.63M -3.42M
Depreciation and amortization 0.25M 0.13M 0.02M -0.02M 0.03M
Operating income -16.74M -9.72M -4.36M -4.61M -3.17M
Other operating expenses 19.82M 13.86M 8.45M 6.27M 4.24M
Interest expense 0.24M 0.17M 0.03M 0.02M 0.06M
Interest income - - 0.01M - 0.00M
Net interest income -0.24M -0.17M -0.88M -0.70M -1.30M
Income tax expense 0.24M 0.17M 0.09M -0.01M -1.13M
Total revenue 3.08M 4.14M 4.08M 1.66M 1.07M
Total operating expenses 18.18M 11.92M 7.02M 5.19M 3.62M
Cost of revenue 1.64M 1.94M 1.43M 1.08M 0.62M
Total other income expense net -0.24M -0.17M -0.33M -0.17M -1.37M
Net income from continuing ops -16.98M -9.89M -15.08M -16.53M -13.31M
Net income applicable to common shares -16.98M -9.89M -15.08M -16.53M -13.31M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 16.41M 30.19M 32.28M 10.34M 7.32M
Other current assets 0.62M 1.54M 1.98M 16.19M 1.40M
Total liab 4.25M 4.77M 5.32M 5.75M 4.69M
Total stockholder equity 12.16M 25.42M 26.96M 4.58M 2.63M
Other current liab 2.96M 2.81M 2.03M 3.05M 3.07M
Common stock - - - 5.03M 3.47M
Capital stock 0.00M 0.00M 0.00M 5.03M 3.47M
Retained earnings -90.06M -75.41M -58.43M -56.97M -48.54M
Other liab - - 0.62M 5.65M 3.30M
Other assets - 0.03M 0.33M 0.12M 0.14M
Cash 10.53M 23.66M 25.62M 3.50M 5.78M
Total current liabilities 3.87M 4.34M 4.02M 3.91M 3.63M
Current deferred revenue 0.19M 0.65M 0.88M - -
Net debt -9.93M -23.06M -24.71M -3.20M -5.53M
Short term debt 0.22M 0.17M 0.22M 0.21M 0.13M
Short long term debt total 0.60M 0.60M 0.91M 0.30M 0.25M
Other stockholder equity 102.22M 100.83M 85.39M 56.52M 47.70M
Property plant equipment - 2.02M 1.63M 2.00M 1.31M
Total current assets 14.18M 28.13M 30.32M 9.68M 6.90M
Net tangible assets - 25.42M 26.96M 14.74M 9.09M
Short term investments 0.53M - - - -
Net receivables 0.23M 1.32M 0.77M 0.88M 0.36M
Inventory 2.27M 2.86M 1.96M 1.14M 0.72M
Accounts payable 0.50M 0.71M 0.88M 0.64M 0.43M
Non currrent assets other 0.03M 0.03M 0.33M 0.04M 0.04M
Non current assets total 2.23M 2.06M 1.96M 0.66M 0.42M
Capital lease obligations 0.60M 0.60M 0.91M 0.97M 0.85M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.89M 4.62M -15.00M -15.00M -15.00M
Change to liabilities -0.17M 0.24M 0.34M 7.90M 1.70M
Total cashflows from investing activities -0.89M 3.79M -15.81M -0.35M -0.24M
Net borrowings - - -0.55M -0.36M -3.49M
Total cash from financing activities 13.58M 30.89M 5.95M 3.06M 5.98M
Change to operating activities 0.91M -2.14M 1.52M 0.41M 0.35M
Net income -16.98M -9.89M -4.69M -4.77M -3.53M
Change in cash -1.96M 22.12M -2.72M 1.22M 2.85M
Begin period cash flow 25.62M 3.50M 6.22M 4.56M 1.34M
End period cash flow 23.66M 25.62M 3.50M 5.78M 4.19M
Total cash from operating activities -14.29M -12.61M -3.72M -1.74M -3.06M
Issuance of capital stock 13.57M 30.55M 6.20M 3.37M 6.91M
Depreciation 0.25M 0.13M 0.27M 0.16M 0.03M
Other cashflows from investing activities - -0.30M -0.05M -0.05M -0.05M
Change to inventory -0.90M -0.89M -0.37M -0.01M -0.38M
Change to account receivables 0.38M -0.36M -0.24M 0.62M -0.60M
Other cashflows from financing activities 0.00M 0.34M -0.08M -0.31M -0.93M
Change to netincome - 0.32M 1.85M 1.06M 1.39M
Capital expenditures 0.89M 0.53M 0.24M 0.10M 0.06M
Change in working capital 0.21M -3.16M 0.13M 2.57M 0.01M
Stock based compensation 1.86M 0.32M 0.23M 0.36M 0.21M
Other non cash items 0.36M 0.01M 0.31M -0.06M 0.21M
Free cash flow -15.18M -13.14M -3.96M -1.84M -3.13M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ICCM
Icecure Medical		 0.14
20.46%		 0.82 - - 17.70 4.70 14.46 -3.06
ABT
Abbott Laboratories		 -0.36
0.33%		 109.56 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.14
0.14%		 101.66 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -0.84
0.26%		 325.03 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.56
1.12%		 50.41 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Icecure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

7 Ha?Eshel Street, Caesarea, Israel, 3079504

972 4 623 0333

https://icecure-medical.com

71

Name Title Year Born
Mr. Eyal Shamir CEO & Director 1961
Mr. Ronen Tsimerman CPA CFO & COO 1969
Ms. Tlalit Bussi Tel-Tzure VP of Bus. Devel. & Global Marketing 1971
Ms. Merav Nir Dotan VP of HR 1969
Mr. Naum Muchnik VP of Research, Devel. & Engineering 1976
Mr. Shay Levav VP of Regulatory and Quality Assurance & Clinical Applications 1977
Ms. Tlalit Bussi Tel-Tzure Vice President of Business Development & Global Marketing 1971
Ms. Merav Nir Dotan Vice President of Human Resources 1969
Ms. Galit Malik Vice President of Operations & Service 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.96
+38.15%
MOON
CAD 4.83
+9.64%
PDN
CAD 8.13
+7.68%
BDT
CAD 72.82
+6.65%
HG
CAD 4.28
+6.20%
CSU
CAD 3300.00
-6.42%
CURA
CAD 12.68
-4.16%
DIV
CAD 3.93
-3.44%
SOIL
CAD 7.18
-3.10%
OBE
CAD 13.31
-2.92%

Equity Sectors*

  • Basic Materials

    +3.63%

  • Communication Services

    -1.14%

  • Consumer Cyclical

    +0.75%

  • Consumer Defensive

    -0.36%

  • Energy

    +2.18%

  • Financial Services

    +1.33%

  • Healthcare

    +1.49%

  • Industrials

    +2.99%

  • Real Estate

    +0.41%

  • Technology

    +1.45%

  • Utilities

    +1.09%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…